SUBSCRIBE
SUBSCRIBE

Biogen

NEWS
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Business
Tiny Forward Pharma Rockets on $1.25 Billion Cash Deal With Biogen
January 17, 2017
 · 
2 min read
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Drug Development
New Spinraza Data Has Biogen Screaming ‘It’s Worth It!’
January 13, 2017
 · 
3 min read
JPM17: Why the Key to Gene Therapy Could be in an Old Bay Area Warehouse
Drug Development
JPM17: New Biogen CEO on Groundbreaking Alzheimer’s Trial and the Company’s Future
January 11, 2017
 · 
2 min read
Former Biogen CEO to Helm Newly Launched Bay Area Startup Vir Biotechnology
Business
Former Biogen CEO to Helm Newly Launched Bay Area Startup Vir Biotechnology
January 6, 2017
 · 
2 min read
Genetown
Did Biogen Just Throw In The Towel To Celgene?
January 4, 2017
 · 
1 min read
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Genetown
Like It or Not: Here’s How Much Biogen’s Spinraza Will Cost
December 29, 2016
 · 
2 min read
What You Missed: Nippon Fine Chemical Formed Human Barricade to Stop FDA Employee
FDA
FDA Approves First-Ever Treatment for Spinal Muscular Atrophy; Ionis Pharma, Biogen Seal Victory
December 27, 2016
 · 
3 min read
Deals
Why Biogen’s New CEO Stands To Gain From An Acquisition
December 22, 2016
 · 
1 min read
Genetown
Here’s Why Investors Weren’t Excited About Biogen’s New CEO
December 20, 2016
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Genetown
Biogen Idec, Inc. (Massachusetts) to Present at the 2013 RBC Capital Markets Global Healthcare Conference
February 21, 2013
 · 
1 min read
Genetown
Biogen Idec, Inc. (Massachusetts) to Present at the Citi 2013 Global Healthcare Conference
February 20, 2013
 · 
1 min read
Drug Development
Biogen Idec, Inc. (Massachusetts) Release: New Phase 3 Data Reinforce Long-Lasting Protection From Bleeding for Patients With Hemophilia A and B
February 8, 2013
 · 
1 min read
Business
Biogen Idec, Inc. (Massachusetts) to Buy Elan Corporation PLC’s Tysabri Rights for $3.25 Billion
February 6, 2013
 · 
9 min read
2013 Facility of the Year Awards (FOYA) Winners Announced, Biogen Idec, Inc. (Massachusetts) and F. Hoffmann-La Roche Ltd. Among Them
January 29, 2013
 · 
2 min read
Drug Development
Biogen Idec, Inc. (Massachusetts) Says MS Drug Worked in Broad Study
January 24, 2013
 · 
5 min read
Policy
Biogen Idec, Inc. (Massachusetts), Elan Corporation PLC Makes Play for Bigger Tysabri Market
January 16, 2013
 · 
6 min read
Business
Biogen Idec, Inc. (Massachusetts) to Report Fourth Quarter & Year End 2012 Financial Results on January 28, 2013
January 15, 2013
 · 
1 min read
Business
Biogen Idec, Inc. (Massachusetts) to Report Fourth Quarter & Year End 2012 Financial Results on January 28, 2013
January 15, 2013
 · 
1 min read
Policy
Teva Pharmaceutical Industries Limited Asks FDA Not to Approve Biogen Idec, Inc. (Massachusetts) MS Drugs
January 10, 2013
 · 
1 min read
Load More